Press Releases

Date Title and Summary
Toggle Summary Accuray Synchrony® Real-time Adaptive Technology for the Radixact® System Wins 2020 MedTech Breakthrough Award
Annual Awards Program Recognizes Outstanding Health & Medical Technology Products and Companies SUNNYVALE, Calif. , May 19, 2020 /PRNewswire/ --  Accuray Incorporated  (NASDAQ: ARAY) today announced that MedTech Breakthrough , an independent market intelligence organization that recognizes the top
Toggle Summary Accuray Reports Fiscal 2020 Third Quarter Financial Results
SUNNYVALE, Calif. , April 28, 2020 /PRNewswire/ --  Accuray Incorporated (NASDAQ: ARAY) today reported its financial results for the third quarter of fiscal 2020 ended March 31, 2020 . Recent Company Highlights Gross orders increased 27% year-over-year to $106.0 million , including 11 orders from
Toggle Summary Accuray To Report Fiscal 2020 Third Quarter Financial Results on April 28, 2020
SUNNYVALE, Calif. , April 16, 2020 /PRNewswire/ --  Accuray Incorporated (NASDAQ: ARAY) will report results for its third quarter ended March 31, 2020 on Tuesday, April 28, 2020 after the market close. Management will host a conference call to review the results at 1:30 p.m. PT / 4:30 p.m.
Toggle Summary Accuray Incorporated Reports Inducement Awards Under NASDAQ Listing Rules
SUNNYVALE, Calif. , March 5, 2020 /PRNewswire/ --  Accuray Incorporated (NASDAQ: ARAY) today reported, as required by NASDAQ Stock Market Rules, equity inducement awards to Michael Hoge , the company's new Senior Vice President, Global Operations. As a material inducement to Mr.
Toggle Summary First Accuray CyberKnife® M6™ System Installed in Missouri at Mercy Hospital St. Louis
SUNNYVALE, Calif. , Feb. 25, 2020 /PRNewswire/ --  Accuray Incorporated (NASDAQ: ARAY) announced today that Mercy Hospital St. Louis continues to demonstrate its commitment to improving patient outcomes with the installation of the first CyberKnife ® M6™ System in Missouri at their state-of-the-art
Toggle Summary Studies Support Use of the Accuray TomoTherapy® System for Advanced Rectal Cancer to Improve Treatment Efficacy and Reduce Side Effects
SUNNYVALE, Calif. , Feb. 5, 2020 /PRNewswire/ --  Accuray Incorporated (NASDAQ: ARAY) announced today that two new studies demonstrate the benefits of the TomoTherapy ® System  in the treatment of advanced rectal cancer. Radiotherapy, with or without chemotherapy, followed by surgery is the
Toggle Summary Accuray Reports Fiscal 2020 Second Quarter Financial Results
SUNNYVALE, Calif. , Jan. 28, 2020 /PRNewswire/ -- Accuray Incorporated (NASDAQ: ARAY) today reported its financial results for the second quarter of fiscal 2020 ended December 31, 2019 . Recent Company Highlights Gross orders of $98.6 million , including 11 orders from China Net orders of $89.9
Toggle Summary Accuray To Report Fiscal 2020 Second Quarter Financial Results on January 28, 2020
SUNNYVALE, Calif. , Jan. 16, 2020 /PRNewswire/ --  Accuray Incorporated (NASDAQ: ARAY) will report results for its second quarter ended December 31, 2019 on Tuesday, January 28, 2020 after the market close. Management will host a conference call to review the results at 1:30 p.m. PT / 4:30 p.m.
Toggle Summary Accuray To Discuss Revenue Growth Expectations for the Next Three Fiscal Years at the JP Morgan Healthcare Conference
Company to present on Wednesday, January 15, 2020 at 10 am PT / 1 pm ET SUNNYVALE, Calif. , Jan. 13, 2020 /PRNewswire/ --  Accuray Incorporated (Nasdaq: ARAY) will be discussing its business and revenue growth expectations for the next three fiscal years at the JP Morgan Healthcare Conference on
Toggle Summary Accuray CyberKnife® System Provides Excellent Disease Control for Men with Recurrent Prostate Cancer, a Medical Condition with Few Viable Treatment Options
SUNNYVALE, Calif. , Jan. 8, 2020 /PRNewswire/ --  Accuray Incorporated (NASDAQ: ARAY) announced today data from a prospective study which showed that at five years, stereotactic body radiation therapy (SBRT) administered with the CyberKnife ® System provided excellent disease control with low rates